Evidence map›Paper›PMID 26635627›Full record

ReviewFrontiers in physiology2015

Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome.

Luiz H A Cavalcante-Silva, José G F M Galvão, Juliane Santos de França da Silva, José M de Sales-Neto, Sandra Rodrigues-Mascarenhas

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2021
    Article
  8. Pb Toxicity on Gut Physiology and Microbiota.Frontiers in physiology · 2021
    Review
  9. Article
  10. Article
  11. The Association Between Normal BMI With Central Adiposity And Proinflammatory Potential Immunoglobulin GDiabetes, metabolic syndrome and obesity : targets and therapy · 2019
    Article
  12. Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans.Cellular and molecular gastroenterology and hepatology · 2017
    Article
  13. Macrophage functions in lean and obese adipose tissue.Metabolism: clinical and experimental · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Distribution and Characteristics of Colonic Diverticula in a United States Screening Population.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2016
    Article
  19. UPDATING THE CONCEPT OF METABOLICALLY HEALTHY OBESITY.Acta endocrinologica (Bucharest, Romania : 2005)
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Luiz H A Cavalcante-SilvaPrograma Multicêntrico de Pós-graduação em Ciências Fisiológicas, Laboratório de Imunofarmacologia, Centro de Biotecnologia, Universidade Federal da Paraíba João Pessoa, Brasil.
José G F M GalvãoPrograma Multicêntrico de Pós-graduação em Ciências Fisiológicas, Laboratório de Imunofarmacologia, Centro de Biotecnologia, Universidade Federal da Paraíba João Pessoa, Brasil.
Juliane Santos de França da SilvaPrograma de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos, Laboratório de Imunofarmacologia, Centro de Ciências da Saúde, Universidade Federal da Paraíba João Pessoa, Brasil.
José M de Sales-NetoPrograma de Pós-Graduação em Biotecnologia, Laboratório de Imunofarmacologia, Centro de Biotecnologia, Universidade Federal da Paraíba João Pessoa, Brasil.
Sandra Rodrigues-MascarenhasPrograma Multicêntrico de Pós-graduação em Ciências Fisiológicas, Laboratório de Imunofarmacologia, Centro de Biotecnologia, Universidade Federal da Paraíba João Pessoa, Brasil ; Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos, Laboratório de Imunofarmacologia, Centro de Ciências da Saúde, Universidade Federal da Paraíba João Pessoa, Brasil ; Programa de Pós-Graduação em Biotecnologia, Laboratório de Imunofarmacologia, Centro de Biotecnologia, Universidade Federal da Paraíba João Pessoa, Brasil.
Universidade Federal da Paraíba · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intimate interplay between immune system, metabolism, and gut microbiota plays an important role in controlling metabolic homeostasis and possible obesity development. Obesity involves impairment of immune response affecting both innate and adaptive immunity. The main factors involved in the relationship of obesity with inflammation have not been completely elucidated. On the other hand, gut microbiota, via innate immune receptors, has emerged as one of the key factors regulating events triggering acute inflammation associated with obesity and metabolic syndrome. Inflammatory disorders lead to several signaling transduction pathways activation, inflammatory cytokine, chemokine production and cell migration, which in turn cause metabolic dysfunction. Inflamed adipose tissue, with increased macrophages infiltration, is associated with impaired preadipocyte development and differentiation to mature adipose cells, leading to ectopic lipid accumulation and insulin resistance. This review focuses on the relationship between obesity and inflammation, which is essential to understand the pathological mechanisms governing metabolic syndrome.

Indexed as

adipose tissuecytokinesgut microbiotaimmune systemtoll-like receptors

Identifiers

PMID26635627
PMCPMC4652019
OpenAlexW2212140938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.